J. M. Pericàs

Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells.

S. Schwartz, D. Rafael, I. Abasolo, 2023, Pharmaceutics.

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

N. Lanthier, M. Abdelmalek, Q. Anstee, 2024, The New England journal of medicine.